$JAKK

JAKKS Pacific stock (US47012E1064): Zacks flags high costs hurting prospects

Zacks Investment Research highlighted that JAKKS Pacific faces challenges due to high oil-linked resin costs and cautious retailer behavior. Despite a strong foundation in licensed products from popular brands like Disney and Nintendo, these cost pressures are expected to impact near-term margins. The report emphasizes the need for effective cost management within the competitive US toy market.

Original reporting
AD HOC NEWS · editorial team
Published May 14, 2026, 5:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 14, 2026, 6:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
JAKKS Pacific stock (US47012E1064): Zacks flags high costs hurting prospects — source image
Decision brief

The 30-second read

$JAKKNeutralMed
01

Why it matters

Rising resin costs and retailer caution are expected to squeeze margins in the near term, possibly leading to stock price declines.

02

Market read

The news indicates sector-wide cost challenges that could impact other toy manufacturers and retailers, especially those reliant on similar supply chains.

03

What to watch

Potential for strategic cost-cutting initiatives or product innovation to offset margin pressures; broader economic factors influencing consumer spending.

Relevance 6/10Timing: Immediate to short-term (next 1-3 months)

Background

JAKKS Pacific is a key player in the US toy industry, with a significant portfolio of licensed products from major brands.

Company-level read

Ticker impact

$JAKKNeutralMedium confidence
Context

The news directly pertains to JAKKS Pacific, highlighting cost pressures affecting its near-term margins.

Expected impact

Potential short-term decline of 3-5%, with long-term outlook remaining uncertain pending cost management strategies.

Evidence & confidence

The analysis is based on current cost pressures and retailer sentiment, but lacks detailed financial data and technical indicators to confirm precise price movements.

Market effects

The toy manufacturing and retail sector may experience increased cost pressures, leading to potential margin compression among competitors.

Primarily affecting the US toy market, with possible ripple effects in North American retail channels.

Limited; the impact is localized to the US market and specific to company-level cost issues.

Counterpoint

Cost pressures may be temporary if raw material prices stabilize or if the company successfully passes costs onto consumers.

Key entities

  • JAKKS Pacific

    A US-based toy manufacturer specializing in licensed products.

  • Disney

    Major licensor of popular toy products.

  • Nintendo

    Major licensor of popular toy products.

Related articles

$JAKKMed

JAKKS Pacific (JAKK) Q2 2026 Earnings Call Transcript

JAKKS Pacific held its Q2 2026 earnings call, saying net sales rose 17% to $139.2M year over year and were $245.9M for the first half, up 6%. International shipping hit $53M for the first half. Gross margin was 32.3%. Operating loss was $142K and adjusted EBITDA was $5.4M. The company said it received essentially all IEPA tariff refunds by Q2 close.

LowAI 8/10

Ascletis' Strategic Partner Sagimet Announces First Patient Dosed in Phase III U.S. Clinical Trial of Denifanstat (ASC40) for Moderate to Severe Acne – Thailand Business News

Ascletis Pharma Inc.'s partner, Sagimet Biosciences, has dosed the first patient in a Phase III U.S. trial of denifanstat (ASC40) for moderate to severe acne. The trial aims to enroll 800 patients. Ascletis' prior Phase III trial in China showed ASC40 was more effective than FDA-approved treatments, with 18.6% treatment success vs. 9.4% for sarecycline and 6.7% for doxycycline.